Amlodipin/valsartan Sandoz 5 mg/160 mg filmom obložene tablete
| Name | Amlodipin/valsartan Sandoz 5 mg/160 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-247885415 |
| Active Substance | amlodipinbesilat valsartan |
| Composition | jedna filmom obložena tableta sadrži 5 mg amlodipina (u obliku amlodipinbesilata) i 160 mg valsartana |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Elpen Pharmaceutical Co.Inc. (SA), Pikermi, Attica, Grčka |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 07.10.2026 |
| MA Period of Validity | 07.10.2031 |
| Classification Number | UP/I-530-09/24-01/335 |
| Registration Number | 381-12-01/171-26-08 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09DB01 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Summary of risk management plan | download |
